Interventional Cardiovascular Surgery

In this discussion, Helge Möllman and Eberhard Grube revisit the ongoing debate between TAVI and surgery in the treatment of aortic stenosis. While TAVI continues to expand into younger and more complex patient populations, they emphasise that the dialogue with cardiac surgery remains essential. They highlight the importance...

Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...

The study aimed to evaluate the impact of LAAC device implantation depth on local flow characteristics and its association with device-related thrombus using patient-specific computational fluid dynamics.

The 6-year results of the Evolut Low Risk trial confirm the absence of significant differences in the composite primary endpoint between TAVR and surgery, but introduce an important nuance: the first signal of increased valve reintervention in the TAVR arm within this trial.

Yohei Ohno provides his takeaways from the results of the SURVIV trial, which were presented by Dimytri Siqueira during the ACC.26 in New Orleans.

This case features a 79-year-old patient with severe aortic stenosis and a degenerated surgical bioprosthesis, who previously underwent complex aortic surgery for coarctation.

Redo surgery was high-risk, so a transcatheter valve-in-valve procedure was chosen.

Explore the case to see how anatomy, prosthesis sizing, and vascular access options guide...

This session addresses the complexities of PCI in post-CABG patients, focusing on the application of intravascular imaging and functional assessment to guide strategy. It discusses clinical and anatomical factors influencing the choice between native vessel and graft PCI, and explores management techniques for unyielding graft lesions,...

This session highlights collaborative approaches between interventional cardiologists and surgeons in complex valve interventions. It includes cases such as transfemoral valve-in-valve TAVI in bio-Bentall patients with chronic aortic dissection, critical decision-making in life-threatening scenarios, the importance of access choice in TMVR, mechanical leaflet modification of failed...

Philippe Généreux and Philippe Pibarot discuss the long-term findings from PARTNER 3 and their practical implications for patient care.

They review the 7-year comparison of transfemoral TAVR versus surgical aortic-valve replacement in symptomatic patients with severe aortic stenosis who are at low surgical risk, and why the...

This session offers a compelling case-based exploration of emergency transcatheter valve interventions, demonstrating their potential as life-saving alternatives or bridges to surgery in high-risk patients. Through detailed clinical scenarios including cardiogenic shock, acute papillary muscle rupture, and severe aortic regurgitation from infective endocarditis, participants gain practical...